Klaria Pharma Holding AB (FRA:6FN) OCF Margin %: -88.89% (As of Mar. 2026)


FRA:6FN Klaria Pharma Holding AB FRA:6FN
28 GF Score
Price €0.06
GF Value €0.03
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Klaria Pharma Holding AB OCF Margin %?

Klaria Pharma Holding AB FRA:6FN -8.28% 28 OCF Margin % is -88.89% as of Mar. 2026. GuruFocus rates FRA:6FN with a GF Score™ of 28/100 and a GF Value™ of €0.03 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 957 Drug Manufacturers companies, Klaria Pharma Holding AB ranks worse than 99.69% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Klaria Pharma Holding AB's Cash Flow from Operations for the three months ended in Mar. 2026 was €-0.01 Mil. Klaria Pharma Holding AB's Revenue for the three months ended in Mar. 2026 was €0.01 Mil. Therefore, Klaria Pharma Holding AB's OCF Margin % for the quarter that ended in Mar. 2026 was -88.89%.

As of today, Klaria Pharma Holding AB's current OCF Yield % is -18.78%.

The historical rank and industry rank for Klaria Pharma Holding AB's OCF Margin % or its related term are showing as below:

FRA:6FN' s OCF Margin % Range Over the Past 10 Years
Min: -847.46   Med: -460.03   Max: -107.14
Current: -25223.08


During the past 12 years, the highest OCF Margin % of Klaria Pharma Holding AB was -107.14%. The lowest was -847.46%. And the median was -460.03%.

FRA:6FN's OCF Margin % is ranked worse than
99.69% of 957 companies
in the Drug Manufacturers industry
Industry Median: 9.95 vs FRA:6FN: -25223.08


Klaria Pharma Holding AB OCF Margin % Related Terms


Klaria Pharma Holding AB OCF Margin % Historical Data

* Premium members only.

The historical data trend for Klaria Pharma Holding AB's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Klaria Pharma Holding AB OCF Margin % Chart

Klaria Pharma Holding AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -847.00 -107.14 -532.31 -389.83

Klaria Pharma Holding AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.24 0.00 -70,950.00 0.00 -88.89

FRA:6FN vs ZTS, UTHR: OCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Klaria Pharma Holding AB's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Klaria Pharma Holding AB OCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Klaria Pharma Holding AB's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Klaria Pharma Holding AB's OCF Margin % falls into.


FRA:6FN
28GF Score
Klaria Pharma Holding AB FRA:6FN
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Klaria Pharma Holding AB OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Klaria Pharma Holding AB's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-3.22/0.826
=-389.83 %

Klaria Pharma Holding AB's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.008/0.009
=-88.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -88.89% mean?
Klaria Pharma Holding AB (FRA:6FN) has a OCF Margin % of -88.89% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Klaria Pharma Holding AB and its competitors. According to the industry distribution chart, Klaria Pharma Holding AB ranks #954 out of 957 companies in the Drug Manufacturers industry, placing it in the top 99.7%.
Is Klaria Pharma Holding AB's OCF Margin % too high?
Klaria Pharma Holding AB's current OCF Margin % is -88.89%. Based on the distribution chart, Klaria Pharma Holding AB ranks #954 out of 957 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Klaria Pharma Holding AB has a GF Score™ of 28/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Klaria Pharma Holding AB's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Klaria Pharma Holding AB ranks #954 out of 957 companies for OCF Margin %. This places Klaria Pharma Holding AB in the lower half of its industry. The industry median OCF Margin % is 9.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 957 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Klaria Pharma Holding AB and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Klaria Pharma Holding AB's current OCF Margin % is -88.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Klaria Pharma Holding AB stock overvalued right now?
Based on GuruFocus' analysis, Klaria Pharma Holding AB (FRA:6FN) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.03, compared to a current price of €0.06 — trading 99.3% above its estimated fair value. The current OCF Margin % is -88.89%. Klaria Pharma Holding AB's overall GF Score™ is 28/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Klaria Pharma Holding AB (FRA:6FN), the current OCF Margin % is -88.89% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Klaria Pharma Holding AB (FRA:6FN) Overvalued in 2026?

Based on GuruFocus' analysis, Klaria Pharma Holding AB stock appears to be overvalued. The current stock price of €0.06 is trading 99.3% above its estimated GF Value™ of €0.03. GuruFocus considers Klaria Pharma Holding AB to be Significantly Overvalued.

Key valuation signals for FRA:6FN:

  • OCF Margin %: -88.89%
  • GF Value™: €0.03 vs. price of €0.06 (99.3% above fair value)
  • GF Score™: 28/100 with 6 warning signs

No single metric tells the full story. See the FRA:6FN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Klaria Pharma Holding AB Business Description

Other Exchanges KLAR:Sweden
Address Virdings Alle 2, Uppsala, CHE, 754 50
Klaria Pharma Holding AB is a Swedish pharmaceutical company that develops rapid-acting products. By combining patented technology of a film that attaches to the oral mucosa and pharmaceuticals, the company has developed a drug distribution concept with many benefits and potential uses. Its patented drug delivery platform consists of an alginate-based polymer film that enables the absorption of a product's active substance through the oral mucosa.
28GF Score

Get the complete analysis for FRA:6FN

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.06
Price
€0.03
GF Value